Skip to content

Suprainguinal Fascia Iliaca Block vs. Periarticular Injection for Total Knee Arthroplasty

Ultrasound Guided Suprainguinal Fascia Iliaca Block vs. Periarticular Injection for Total Knee Arthroplasty: Prospective Randomized Study

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05636449
Enrollment
70
Registered
2022-12-05
Start date
2022-11-25
Completion date
2023-05-30
Last updated
2023-06-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Analgesia

Brief summary

Total knee replacement (total knee arthroplasty) is performed to resurface a knee damaged by arthritis and relieve pain in patients with severely damaged knee joints. Total knee arthroplasty (TKA) is associated with severe postoperative pain, and the management of postoperative pain continues to evolve with the advancement of surgical techniques and pharmacological treatments. Femoral, lateral femoral cutaneous nerve and obturator nerve block is provided with suprainguinal fascia iliaca plan block, which is used for postoperative analgesia, especially in hip surgeries. In this way, the investigators think it can be used as a part of multimodal analgesia in total knee arthroplasty surgery.

Interventions

OTHERGroup Suprainguinal fascia iliaca block

After the operation is completed, the fascia iliaca will be separated from the iliacus muscle. With ultrasound guidance, the local anesthetic injection will be made between the fascia and the muscle.

OTHERGroup Periarticular Infiltration

A total volume of 80 ml local anesthetic will be applied to the medial and lateral capsule, the medial and lateral meniscus margins, the deep part of the medial ligament, the medial and lateral synovial space, and the patellar ligament and quadriceps tendon.

Sponsors

Ataturk University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
TRIPLE (Subject, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 70 Years
Healthy volunteers
No

Inclusion criteria

* American Society of Anesthesiologist's physiologic state I-III patients * Total knee arthroplasty

Exclusion criteria

* BMI\>35 * liver, kidney, and advanced heart failure, * routine use of analgesics and * having used analgesics in the last 24 hours, * having neuropathic pain, * refusal to participate in the study

Design outcomes

Primary

MeasureTime frameDescription
Postoperative opioid consumptionfirst 24 hoursFirst 24 hours total fentanyl consumption with patient controlled analgesia

Secondary

MeasureTime frameDescription
timed up and go test (TUG)at 24th hourTUG- evaluation of the time in seconds for the patient to get up from the chair and walk 3 meters and return to the chair again
quadriceps muscle strengthat 24th hourwill be evaluated in a scale between 1-5 (1:lowest; 5:normal)
joint range of motion test (ROM)at 24th hourwill be measured with goniometer( between 0-180 degrees)
Visual analog pain scorefirst 48 hoursPost operative pain will be evaluated with a Visual Analogue Scale (between 0-10; 0: no pain, 10:worst pain) score
Five Time Sit to Stand Test (FTSST)at 24th hourphysical assistance of the patient getting up and sitting down 'as fast as possible' five times without

Countries

Turkey (Türkiye)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026